Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Pharmacopsychiatry
|
November 20, 2004
Sleepwalking associated with reboxetine in a young female patient with major depression--a case report
H E Künzel, A Schuld, T Pollmächer
Versicherungsmedizin
|
June 28, 2006
[Chronic pain and depression]
H E Künzel, A Schuld, T Pollmächer
Molecular Psychiatry
|
September 30, 2003
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects
M A Dalal, A Schuld, T Pollmächer
Journal of Clinical Psychopharmacology
|
September 23, 2000
Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: is the sigma receptor involved?
A Schuld, J J Archelos, E Friess
Der Nervenarzt
|
March 17, 2004
[Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness]
A Schuld, D Hinze-Selch, Th Pollmächer
Psychosomatic Medicine
|
August 4, 2001
Effects of sleep on endotoxin-induced host responses in healthy men
M Haack, A Schuld, T Kraus, et al.
Lancet (London, England)
|
April 19, 2000
Increased body-mass index in patients with narcolepsy
A Schuld, J Hebebrand, F Geller, et al.
Journal of Sleep Research
|
January 26, 2000
Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder
A Schuld, T Kraus, M Haack, et al.
Acta Psychiatrica Scandinavica
|
August 11, 2000
Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia
A Schuld, T Kraus, D Hinze-Selch, et al.
Fortschritte Der Neurologie-Psychiatrie
|
September 5, 2001
[On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors]
T Pollmächer, A Schuld, T Kraus, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Pharmacopsychiatry
|
November 20, 2004
Sleepwalking associated with reboxetine in a young female patient with major depression--a case report
H E Künzel, A Schuld, T Pollmächer
Versicherungsmedizin
|
June 28, 2006
[Chronic pain and depression]
H E Künzel, A Schuld, T Pollmächer
Molecular Psychiatry
|
September 30, 2003
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects
M A Dalal, A Schuld, T Pollmächer
Journal of Clinical Psychopharmacology
|
September 23, 2000
Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: is the sigma receptor involved?
A Schuld, J J Archelos, E Friess
Der Nervenarzt
|
March 17, 2004
[Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness]
A Schuld, D Hinze-Selch, Th Pollmächer
Psychosomatic Medicine
|
August 4, 2001
Effects of sleep on endotoxin-induced host responses in healthy men
M Haack, A Schuld, T Kraus, et al.
Lancet (London, England)
|
April 19, 2000
Increased body-mass index in patients with narcolepsy
A Schuld, J Hebebrand, F Geller, et al.
Journal of Sleep Research
|
January 26, 2000
Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder
A Schuld, T Kraus, M Haack, et al.
Acta Psychiatrica Scandinavica
|
August 11, 2000
Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia
A Schuld, T Kraus, D Hinze-Selch, et al.
Fortschritte Der Neurologie-Psychiatrie
|
September 5, 2001
[On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors]
T Pollmächer, A Schuld, T Kraus, et al.
Page
of 4